AstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 9, pp. 2691-2702

2022

  1. Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

    Pharmaceutics, Vol. 14, Núm. 5